Is Shi Weiya a state-owned enterprise or a foreign enterprise?

According to Aiqi's investigation, Shiweiya (Tianjin) Pharmaceutical Co., Ltd. is an international pharmaceutical company managed by a non-profit fund, headquartered in Surene, France, and its business covers all over the world 150 countries. A total of 265,438+0,800 employees worldwide are committed to promoting medical reform, innovation and upgrading, and providing patients with high-quality drugs and key health solutions. As a leading independent enterprise in the world, the Group spends an average of 20% of its brand drug revenue on drug research and development every year. At the same time, the Group maintains long-term open cooperation with academic institutions, pharmaceutical companies and biotechnology companies, thus accelerating medical innovation, benefiting more patients and creating a world that can ensure that all people can obtain quality health services. While maintaining the leading position in the field of cardiology, Sviya Group actively expands the field of oncology and strives to become an outstanding contributor in the field of oncology.

1988 was awarded the reputation of the most creative pharmaceutical factory in the world by SCRIP Medical magazine. Today, Sylvia has offices in more than 65,438+035 countries and more than 65,438+03,000 employees worldwide. Schwiya Pharmaceutical Factory is the largest private pharmaceutical group in France. France's Schwier Pharmaceutical Factory can achieve such achievements mainly because of its emphasis on scientific research. Every year, pharmaceutical companies extract a quarter of their total turnover as research funds, so that pharmaceutical companies can continuously develop and produce new prescription drugs with therapeutic value and few side effects.